155 related articles for article (PubMed ID: 35940363)
1. Evaluation of an Integrated Spectroscopy and Classification Platform for Point-of-Care Core Needle Biopsy Assessment: Performance Characteristics from Ex Vivo Renal Mass Biopsies.
Keshavamurthy KN; Dylov DV; Yazdanfar S; Patel D; Silk T; Silk M; Jacques F; Petre EN; Gonen M; Rekhtman N; Ostroverkhov V; Scher HI; Solomon SB; Durack JC
J Vasc Interv Radiol; 2022 Nov; 33(11):1408-1415.e3. PubMed ID: 35940363
[TBL] [Abstract][Full Text] [Related]
2. Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.
Coy H; Hsieh K; Wu W; Nagarajan MB; Young JR; Douek ML; Brown MS; Scalzo F; Raman SS
Abdom Radiol (NY); 2019 Jun; 44(6):2009-2020. PubMed ID: 30778739
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.
Lee HS; Hong H; Jung DC; Park S; Kim J
Med Phys; 2017 Jul; 44(7):3604-3614. PubMed ID: 28376281
[TBL] [Abstract][Full Text] [Related]
4. Textural differences between renal cell carcinoma subtypes: Machine learning-based quantitative computed tomography texture analysis with independent external validation.
Kocak B; Yardimci AH; Bektas CT; Turkcanoglu MH; Erdim C; Yucetas U; Koca SB; Kilickesmez O
Eur J Radiol; 2018 Oct; 107():149-157. PubMed ID: 30292260
[TBL] [Abstract][Full Text] [Related]
5. The success rate of small renal mass core needle biopsy and its impact on lowering benign resection rate.
Gao H; Nowroozizadeh B; Zepeda JP; Landman J; Farzaneh T; Johnson C; Hosseini H; Han M
BMC Urol; 2023 Nov; 23(1):189. PubMed ID: 37980518
[TBL] [Abstract][Full Text] [Related]
6. Human feasibility study of fluorescence spectroscopy guided optical biopsy needle for prostate cancer diagnosis.
Werahera PN; Jasion EA; Liu Y; Daily JW; Arangua P; Jones C; Nash SR; Morrell M; Crawford ED
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():7358-61. PubMed ID: 26737991
[TBL] [Abstract][Full Text] [Related]
7. Touch preparation for rapid onsite evaluations of renal mass biopsies: concordance rate, pearls, and pitfalls.
Ponce-Zepeda J; Nowroozizadeh B; Lu D; Farzaneh T; Han M
J Am Soc Cytopathol; 2020; 9(5):422-428. PubMed ID: 32616449
[TBL] [Abstract][Full Text] [Related]
8. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
[TBL] [Abstract][Full Text] [Related]
9. Radiogenomics in Clear Cell Renal Cell Carcinoma: Machine Learning-Based High-Dimensional Quantitative CT Texture Analysis in Predicting PBRM1 Mutation Status.
Kocak B; Durmaz ES; Ates E; Ulusan MB
AJR Am J Roentgenol; 2019 Mar; 212(3):W55-W63. PubMed ID: 30601030
[TBL] [Abstract][Full Text] [Related]
10. Predicting common solid renal tumors using machine learning models of classification of radiologist-assessed magnetic resonance characteristics.
Lopes Vendrami C; McCarthy RJ; Villavicencio CP; Miller FH
Abdom Radiol (NY); 2020 Sep; 45(9):2797-2809. PubMed ID: 32666233
[TBL] [Abstract][Full Text] [Related]
11. The impact of location and number of cores on the diagnostic accuracy of renal mass biopsy: an ex vivo study.
Hobbs DJ; Zhou M; Campbell SC; Aydin H; Weight CJ; Lane BR
World J Urol; 2013 Oct; 31(5):1159-64. PubMed ID: 22527673
[TBL] [Abstract][Full Text] [Related]
12. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
13. Optical spectroscopy techniques can accurately distinguish benign and malignant renal tumours.
Couapel JP; Senhadji L; Rioux-Leclercq N; Verhoest G; Lavastre O; de Crevoisier R; Bensalah K
BJU Int; 2013 May; 111(6):865-71. PubMed ID: 22934843
[TBL] [Abstract][Full Text] [Related]
14. Is Core Needle Biopsy Reliable in Differentiating Between Aggressive Benign and Malignant Radiolucent Bone Tumors?
Hegde V; Burke ZDC; Park HY; Zoller SD; Johansen D; Kelley BV; Levine B; Motamedi K; Federman NC; Seeger LL; Nelson SD; Bernthal NM
Clin Orthop Relat Res; 2018 Mar; 476(3):568-577. PubMed ID: 29529643
[TBL] [Abstract][Full Text] [Related]
15. Depletion of Core Needle Biopsy Cellularity and DNA Content as a Result of Vigorous Touch Preparations.
Rekhtman N; Kazi S; Yao J; Dogan S; Yannes A; Lin O; Silk M; Silk T; Durack JC
Arch Pathol Lab Med; 2015 Jul; 139(7):907-12. PubMed ID: 25521802
[TBL] [Abstract][Full Text] [Related]
16. Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up. Alderman MA, Daignault S, Wolf JS Jr, Palapattu GS, Weizer AZ, Hafez KS, Kunju LP, Wu AJ. Hum Pathol.September 2016;55:1-10.
Kryvenko ON
Urol Oncol; 2017 Jun; 35(6):452-453. PubMed ID: 28416106
[TBL] [Abstract][Full Text] [Related]
17. Individualized renal mass biopsy strategy for Chinese patients with different subtypes and necrosis area.
Shi GH; Chen Y; Yao XD; Zhang SL; Dai B; Feng LQ; Zhang HL; Shen YJ; Zhu Y; Zhu YP; Xiao WJ; Ma CG; Wen LG; Qin XJ; Yang LF; Ye DW
Urol Oncol; 2013 Aug; 31(6):920-3. PubMed ID: 23886035
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance and Interreader Agreement of a Standardized MR Imaging Approach in the Prediction of Small Renal Mass Histology.
Kay FU; Canvasser NE; Xi Y; Pinho DF; Costa DN; Diaz de Leon A; Khatri G; Leyendecker JR; Yokoo T; Lay AH; Kavoussi N; Koseoglu E; Cadeddu JA; Pedrosa I
Radiology; 2018 May; 287(2):543-553. PubMed ID: 29390196
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen.
Barocas DA; Mathew S; DelPizzo JJ; Vaughan ED; Sosa RE; Fine RG; Akhtar M; Scherr DS
BJU Int; 2007 Feb; 99(2):290-5. PubMed ID: 17092279
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.
Tordjman M; Mali R; Madelin G; Prabhu V; Kang SK
Eur Radiol; 2020 Jul; 30(7):4023-4038. PubMed ID: 32144458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
